Axsome Therapeutics (AXSM) Q4 2023 Earnings Call Transcript

AXSM earnings call for the period ending December 31, 2023.

Related Keywords

,David Amsellem ,Marc Goodman Leerink ,Leonid Timashev ,Vikram Purohit ,David Amsellem Piper Sandler ,Graig Suvannavejh ,Matt Kaplan Ladenburg Thalmann ,Joon Lee ,America Merrill Lynch ,Marc Goodman ,Myles Minter William Blair ,David Hoang ,Vikram Purohit Morgan Stanley ,Charles Duncan Cantor Fitzgerald ,Herriot Tabuteau ,Mark Jacobson ,Jason Gerberry ,Piper Sandler ,Eddie Hickman Guggenheim ,Myles Minter ,Joseph Thome ,David Hoang Citi ,Matt Kaplan ,Hunter Murdock ,Asim Rana Truist ,Charles Duncan ,Yatin Suneja ,Nick Pizzie ,Graig Suvannavejh Mizuho ,William Blair ,Exchange Commission ,Citigroup ,Company Analyst ,Jason Gerberry Bank ,Morgan Stanley ,Ladenburg Thalmann ,Cantor Fitzgerald ,Axsome Therapeutics ,Chief Operating Officer Mark ,Motley Fool Stock Advisor ,Stock Advisor ,Ari Maizel ,Vice President ,Epworth Sleepiness Scale ,Yash Verma ,Truist Securities ,Mizuho Securities ,